Zhang Y - Search Results

1

Metabolism of a sulfur-containing heteroarotionoid antitumor agent, SHetA2, using liquid chromatography/tandem mass spectrometry.

Liu Z, Zhang Y, Hua YF, Covey JM, Benbrook DM, Chan KK. Liu Z, et al. Among authors: zhang y. Rapid Commun Mass Spectrom. 2008 Nov;22(21):3371-81. doi: 10.1002/rcm.3744. Rapid Commun Mass Spectrom. 2008. PMID: 18837006

2

High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2.

Zhang Y, Hua Y, Benbrook DM, Covey JM, Dai G, Liu Z, Chan KK. Zhang Y, et al. Cancer Chemother Pharmacol. 2006 Nov;58(5):561-9. doi: 10.1007/s00280-006-0211-z. Epub 2006 Mar 14. Cancer Chemother Pharmacol. 2006. PMID: 16534614

3

Phase I and pharmacokinetic study of erlotinib (OSI-774) in combination with docetaxel in squamous cell carcinoma of the head and neck (SSCHN).

Kraut EH, Rhoades C, Zhang Y, Cheng H, Aimiumu J, Chen P, Lang J, Young DC, Agrawal A, Dancey J, Chan KK, Grever MR. Kraut EH, et al. Among authors: zhang y. Cancer Chemother Pharmacol. 2011 Mar;67(3):579-86. doi: 10.1007/s00280-010-1332-y. Epub 2010 May 19. Cancer Chemother Pharmacol. 2011. PMID: 20490801 Free PMC article. Clinical Trial.

4

Expedited Approval of Urgently Needed Drugs in China.

Wei Y, Zhang Y, Li H, Shi L, Guan X. Wei Y, et al. Among authors: zhang y. JAMA Health Forum. 2025 Jan 3;6(1):e244750. doi: 10.1001/jamahealthforum.2024.4750. JAMA Health Forum. 2025. PMID: 39752173

5

Xanthohumol attenuates TXNIP-mediated renal tubular injury in vitro and in vivo diabetic models.

Zhang Y, Pan R, Shou Z, Zhao Y. Zhang Y, et al. J Nat Med. 2025 Jan 3. doi: 10.1007/s11418-024-01863-6. Online ahead of print. J Nat Med. 2025. PMID: 39752106

6

Distinct immune signatures for predicting the immunotherapy efficacy of esophageal squamous cell carcinoma or adenocarcinoma.

Wu P, Qin G, Liu J, Zhao Q, Zhao X, Song X, Wang L, Yang S, Zhang Y. Wu P, et al. Among authors: zhang y. Cancer Immunol Immunother. 2025 Jan 3;74(2):47. doi: 10.1007/s00262-024-03904-1. Cancer Immunol Immunother. 2025. PMID: 39751958

7

Identification of biomarkers for chronic lymphocytic leukemia risk: a proteome-wide Mendelian randomization study.

Jin C, Lu Z, Chen Y, Hu H, Zhou M, Zhang Y, Ouyang G, Li T, Sheng L. Jin C, et al. Among authors: zhang y. Discov Oncol. 2025 Jan 3;16(1):2. doi: 10.1007/s12672-024-01699-2. Discov Oncol. 2025. PMID: 39751938

8

The transcription factor NnNAC100 positively regulates amylopectin biosynthesis by activating NnSBEII in the rhizome of Nelumbo nucifera Gaertn.

Zhao S, Zhang C, Jiao J, Zhang Y, Jiang T, Wu P, Feng K, Li L. Zhao S, et al. Among authors: zhang y. Plant Cell Rep. 2025 Jan 3;44(1):21. doi: 10.1007/s00299-024-03408-3. Plant Cell Rep. 2025. PMID: 39751893

9

Alpha-Glucosidase Inhibitors in Aging and Aging-Related Diseases: Clinical Applications and Relevant Mechanisms.

Zhong L, Yang J, Syed JN, Zhang Y, Tian Y, Fu X. Zhong L, et al. Among authors: zhang y. Aging Dis. 2025 Jan 2. doi: 10.14336/AD.2024.1477. Online ahead of print. Aging Dis. 2025. PMID: 39751859 Review.

10

CCR5 and IL-12 co-expression in CAR T cells improves antitumor efficacy by reprogramming tumor microenvironment in solid tumors.

Tian Y, Zhang L, Ping Y, Zhang Z, Yao C, Shen C, Li F, Wen C, Zhang Y. Tian Y, et al. Among authors: zhang y. Cancer Immunol Immunother. 2025 Jan 3;74(2):55. doi: 10.1007/s00262-024-03909-w. Cancer Immunol Immunother. 2025. PMID: 39751840

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260,521 results

Search Page

Filters